Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Concerns regarding the 2024 revisions of the McDonald criteria for diagnosis of multiple sclerosis.
Video Head Impulse Testing in Relapsing Remitting Multiple Sclerosis: Evaluation of Canal Gains, Asymmetry, and Corrective Saccades with Cerebellar Lesions.
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Mechanistic Considerations Across Relapsing and Progressive Disease.
The EBV-autoimmunity axis: mechanistic insights in SLE, MS and PSC.
Essential elements for guiding patient segmentation in precision pharmacotherapy for rheumatoid arthritis: lessons up to 2025.
Quantitative proteomic profiling of neural cells-specific metabolic reprogramming in response to mitochondrial dysfunction using iMPAQT2.
Oculomotor Vergence Eye Movement Endurance in Normal Vision via Virtual Reality-Integrated Eye Tracking.
Reactive stepping strategies after lateral perturbations in people with multiple sclerosis.
Oligodendrocyte dysfunction in neurodegenerative diseases: pathological features, underlying mechanisms and therapeutic targeting.
Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact.
Plasmalogens in Alzheimer's Disease: A Narrative Review of Dietary Sources, Metabolism, and Neuroprotective Mechanisms.
Oligodendrocyte Piezo2 is a regulator of age-dependent myelin integrity and dysregulated in multiple sclerosis.
PIM1-induced Drp1 phosphorylation disrupts microglial mitophagy and aggravates neuroinflammation.
Temporal context shapes multicue integration in auditory time-to-contact judgments.
Management and long-term haematological and neurological outcomes of Immunoglobulin M and Waldenström's macroglobulinaemia-related neuropathy: A single-centre experience.
Targeting CDK8 dually enhances paclitaxel antitumor efficacy and alleviates chemotherapy-induced peripheral neuropathy in breast cancer.
Effects of peripheral nerve damage on promoting maladaptive plasticity in the spinal cord and brain.
Neuro-Behçet's disease: Clinical spectrum, management, and outcomes from an Indian cohort.
Deep Learning-Accelerated 3D FLAIR Enables Reliable MS Lesion Detection.
Serum FAM19A5 elevation in NMOSD: astrocytic injury or reactive gliosis?
Triple antibody-associated autoimmune encephalitis overlap: a case report of co-existing MOG-IgG, anti-NMDAR, and anti-mGluR5 positivity.
Herpes Simplex Virus Type 1 Infects Schwann Cells via Exosomal CD81, Exploits the MVB-Exosomal Pathway, and Induces Demyelination.
Correction: A novel cell-free intrathecal approach with PRP for the treatment of spinal cord multiple sclerosis in cats.
Protein-enhanced small molecule disruptors of ordered membrane domains.
Diagnostic dilemma in visual loss due to diabetic papillopathy masquerading as optic neuritis.
Pages
« first
‹ previous
…
988
989
990
991
992
993
994
995
996
…
next ›
last »